MD Pediatrix Medical Group Inc

  1. Stocks
  2. Healthcare
  3. NYSE: MD

Price (delayed)

$26.57

Market cap

$2.16B

P/E Ratio

12.47

Dividend/share

N/A

EPS

$2.13

Enterprise value

$2.49B

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 92
Relative Profitability: Rel. Profitability: 74

Pediatrix® Medical Group, Inc. is the nation’s leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across ...

Highlights
The company's EPS has surged by 63% YoY
The net income has surged by 59% year-on-year
The quick ratio has declined by 27% year-on-year
The P/E is 20% above the last 4 quarters average of 10.4
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.mednax.com
Peers: THC UHS CYH

Key stats

What are the main financial stats of MD

MD stock price

How has the Pediatrix Medical Group stock price performed over time
Intraday
1.33%
1 week
-0.15%
1 month
1.64%
1 year
64.52%
YTD
24.22%
QTD
4.9%

Financial performance

How have Pediatrix Medical Group's revenue and profit performed over time
Revenue
$1.95B
Gross profit
$511.77M
Operating income
$215.42M
Net income
$174.81M
Gross margin
26.2%
Net margin
9%
The net income has surged by 59% year-on-year
The net margin has soared by 58% YoY
MD's operating income is up by 31% year-on-year
The operating margin has increased by 31% year-on-year but it has declined by 2.7% since the previous quarter

Price vs fundamentals

How does MD's price correlate with its fundamentals

Growth

What is Pediatrix Medical Group's growth rate over time

Valuation

What is Pediatrix Medical Group stock price valuation
MD P/E details
P/E
12.47
P/B
2.48
P/S
1.08
EV/EBIT
9.56
EV/EBITDA
8.79
EV/Sales
1.28
The company's EPS has surged by 63% YoY
The P/E is 20% above the last 4 quarters average of 10.4
The P/B is 46% above the 5-year quarterly average of 1.7 and 24% above the last 4 quarters average of 2.0
The equity is up by 6% YoY
The stock's price to sales (P/S) is 54% more than its 5-year quarterly average of 0.7 and 20% more than its last 4 quarters average of 0.9

Efficiency

How efficient is Pediatrix Medical Group business performance
The ROIC has soared by 84% YoY and by 8% from the previous quarter
The ROA has soared by 53% YoY
The company's return on sales rose by 43% YoY but it fell by 2.2% QoQ
MD's return on equity is up by 41% year-on-year

Dividends

What is MD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MD.

Financial health

How did Pediatrix Medical Group financials performed over time
The total assets is 71% greater than the total liabilities
The company's current ratio fell by 27% YoY
The quick ratio has declined by 27% year-on-year
The debt is 30% less than the equity
MD's debt to equity is down by 10% year-on-year and by 2.8% since the previous quarter
The equity is up by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.